Breaking

Cyclic Materials on Turning Scrap into Supply as Rare Earths Demand Soars
September Quarter Gold Production Increases by 90%
Altech – $6M Placement to Advance Battery Projects
EUR Sells a Further 3.85 Million CRML Shares for US$50M (A$76M) to a US Institutional Investor
Yvonne Blaszczyk: Gold, Silver, Platinum — Flashpoints Everywhere, Moves Just Starting
Locksley Resources LimitedFormer U.S. Major General Appointed to Advisory Board
Altech Batteries Ltd$6M Placement to Advance Battery Projects
Crypto Market Update: Bitcoin Price Takes Hit Heading into Weekend

Home
Features
- View All On Demos
Buy Now
Search for:

Investing

First patient dosed in Phase IIb imaging for Brain Mets

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Cyclic Materials on Turning Scrap into Supply as Rare Earths Demand Soars

October 14, 2025

Altech – $6M Placement to Advance Battery Projects

October 14, 2025

September Quarter Gold Production Increases by 90%

October 14, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (251)
- Investing (1,269)
- Stocks (209)
- World (675)

Disclaimer: thecapitalstrategies.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 thecapitalstrategies.com | All Rights Reserved

Top

Type above and press Enter to search. Press Esc to cancel.